Community Health Workers Reduce Social Barriers That Affect the Health of Patients With High Blood Pressure and Diabetes.
Launched by MOREHOUSE SCHOOL OF MEDICINE · Apr 11, 2025
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how Community Health Workers (CHWs) can help patients with uncontrolled diabetes and high blood pressure by addressing social barriers that may affect their health. The trial aims to find out if a program led by these workers can lower blood sugar levels and blood pressure in patients receiving care at community health centers. If you or someone you know has Type 2 diabetes with a recent blood sugar test showing levels of 9% or higher, or has high blood pressure readings of 140/90 mmHg or above, you may be eligible to participate in this study.
Participants in the trial can expect to receive support from a Community Health Worker who will help identify and address social needs that may be impacting their health. The study is currently recruiting individuals aged 18 and older, and it does not have a gender requirement. This research is important because it will help community health centers better implement programs to support patients with similar health challenges in the future.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria
- • 18 years or older
- • People with Type 2 diabetes with their most recent hemoglobin A1c test result (a blood test that reflects average blood sugar levels over the past 2-3 months) is greater than or equal to 9%.
- • People with essential hypertension with their last systolic blood pressure (BP) (the top number in a BP reading) is greater than or equal to 140 mmHg or diastolic BP (the bottom number in a BP reading) is greater than or equal to 90 mmHg.
- • Exclusion Criteria
- • People who are less than 18 years old
- • Pregnant people
- • People who don't meet the Type 2 diabetes or hypertension criteria.
About Morehouse School Of Medicine
Morehouse School of Medicine (MSM) is a distinguished institution dedicated to improving health outcomes through education, research, and community service. As a leading academic medical center, MSM focuses on addressing health disparities and enhancing healthcare delivery, particularly in underserved populations. The institution is committed to advancing medical knowledge and innovation through rigorous clinical trials, fostering collaborations that bridge science and community health. With a strong emphasis on training the next generation of healthcare leaders, MSM integrates its research initiatives with a mission to promote equity and access in healthcare for all.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Atlanta, Georgia, United States
Portland, Oregon, United States
Miami, Florida, United States
Patients applied
Trial Officials
Megan Douglas, JD
Principal Investigator
Morehouse School of Medicine
Rachel Gold, PhD, MPH
Principal Investigator
OCHIN, Inc.
Katherine Chung-Bridges, MD, MPH
Principal Investigator
Health Choice Network (HCN)
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported